Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it it launched its Viper and Expedium fenestrated screw systems.
The company said the systems are designed to be used with its Confidence high viscosity spinal cement to restore the integrity of the spinal column in patients with advanced stage spinal tumors. The screw systems are intended to provide stabilization and palliative treatment for patients suffering from spinal cord compression as a results of advanced stage tumors.
The newly launched Viper and Expedium fenestrated screws are designed with a hollow shaft and fenestrations above the screw tip to enable controlled delivery of the Confidence cement into the vertebra for immediate fixation. The systems are designed for open or percutaneous spinal fusion, DePuy Synthes added.
“The ability to inject cement via fenestrated screws is a true game-changer in the field of spinal oncology. The systems are reliable and easy-to-use and can seamlessly be incorporated into open and minimally invasive approaches. The cement working characteristics, delivery system and ability to use standard hardware and tools make the systems extremely efficient,” Dr. Daniel Sciubba of Johns Hopkins Hospital said in a press release.
On Wednesday, Johnson & Johnson’s DePuy Synthes said it acquired spinal nerve localization tech dev Innovative Surgical Solutions, which operates as Sentio, for an undisclosed amount.
Wixom, Mich.-based Sentio has developed a platform designed to provide real-time feedback of nerve location using adhesive sensors applied to the skin, DePuy Synthes said. The system can be set up by OR personnel and does not require a neuromonitoring specialist.
